Sugar metabolism in the crystalline lens.
Research on the sugar metabolism of the crystalline lens, past and preent, is reviewed. The chief energy source in the lens is the Embden-Meyerhof pathway; respiration and oxidative phosphorylation become more important as the lens ages. The function of the alpha-glycerophosphate cycle is not fully understood. The mechanisms involved in cataract formation, including those of hypoglycemic cataract and osmotic cataracts, are discussed. Sugar cataracts can be delayed or prevented with such aldose reductase inhibitors as flavonoids. By inhibiting aldose reductase, the formation and accumulation of sugar alcohols is stopped. This approach may be useful as a medical therapy for human diabetic senile cataracts.
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002386:Cataract / Q000209:etiology / Q000628:therapy; D005693:Galactosemias / Q000150:complications; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D007003:Hypoglycemia / Q000150:complications; D007908:Lens, Crystalline / Q000378:metabolism*; D013012:Sorbitol / Q000378:metabolism; D014994:Xylose / Q000097:blood
D001786:Blood Glucose; D013012:Sorbitol; D014994:Xylose; D000449:Aldehyde Reductase; D005947:Glucose